Truist Financial Forecasts Strong Price Appreciation for Adtalem Global Education (NYSE:CVSA) Stock

Adtalem Global Education (NYSE:CVSA) had its price objective hoisted by equities research analysts at Truist Financial from $130.00 to $140.00 in a report released on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Truist Financial’s price target would indicate a potential upside of 6.15% from the company’s current price.

Other research analysts have also issued research reports about the company. Wall Street Zen lowered Adtalem Global Education from a “buy” rating to a “hold” rating in a report on Saturday. Barrington Research reissued an “outperform” rating and set a $170.00 price objective on shares of Adtalem Global Education in a research report on Friday, April 17th. Zacks Research downgraded Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Finally, Weiss Ratings started coverage on Adtalem Global Education in a research report on Wednesday, February 25th. They issued a “hold (c+)” rating for the company. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $155.00.

Adtalem Global Education Stock Performance

Adtalem Global Education stock traded down $1.85 during trading on Monday, reaching $131.89. The company had a trading volume of 59,437 shares, compared to its average volume of 389,923. The company has a 50-day moving average of $110.78. Adtalem Global Education has a 1-year low of $86.97 and a 1-year high of $156.26. The company has a market capitalization of $4.49 billion, a price-to-earnings ratio of 20.54, a PEG ratio of 1.11 and a beta of 0.63. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.70 and a quick ratio of 0.70.

Adtalem Global Education (NYSE:CVSA) last released its quarterly earnings results on Thursday, May 7th. The company reported $1.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.25. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The firm had revenue of $487.03 million for the quarter. During the same period in the prior year, the business posted $1.92 EPS. Adtalem Global Education’s revenue was up 4.5% compared to the same quarter last year. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. Analysts anticipate that Adtalem Global Education will post 8.05 EPS for the current year.

Insiders Place Their Bets

In other Adtalem Global Education news, Director Michael W. Malafronte bought 8,890 shares of the firm’s stock in a transaction that occurred on Wednesday, March 11th. The stock was purchased at an average price of $100.94 per share, for a total transaction of $897,356.60. Following the completion of the purchase, the director directly owned 25,395 shares in the company, valued at $2,563,371.30. This trade represents a 53.86% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders purchased a total of 37,236 shares of company stock worth $3,752,866 in the last three months. 2.50% of the stock is owned by insiders.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.